Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02343224 · OUTCOME

Number of Participants Meeting Event Free Survival Criteria

Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas · Source last updated 2022-01-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Month 12, Month 24

What was measured

Event free survival is the time to treatment failure from the time of study enrollment to tumor progression, tumor recurrence, death from any cause or occurrence of a second malignant neoplasm.

Groups in this outcome

PEGINTRON

Participants with juvenile pilocytic astrocytomas or optic pathway gliomas receiving PEGINTRON based on their weight (1 mcg/kg/dose) once a week, for up to two years

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
PEGINTRON9

Reported measurements

Month 12
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
PEGINTRON7Not reportedNot reportedNot reportedNot reported
Month 24
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
PEGINTRON7Not reportedNot reportedNot reportedNot reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. ci Lower Limit
    52.1
    ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    ci Upper Limit
    100
    group Description
    This Kaplan-Meier estimate is the conditional probability of event-free survival among study participants at 12 and 24 months.
    group Ids
    1. OG000
    non Inferiority Type
    OTHER
    param Type
    Kaplan-Meier estimate
    param Value
    76.2
Complete source fields
analyses
  1. ci Lower Limit
    52.1
    ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    ci Upper Limit
    100
    group Description
    This Kaplan-Meier estimate is the conditional probability of event-free survival among study participants at 12 and 24 months.
    group Ids
    1. OG000
    non Inferiority Type
    OTHER
    param Type
    Kaplan-Meier estimate
    param Value
    76.2
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        7
    title
    Month 12
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        7
    title
    Month 24
denoms
  1. counts
    1. group Id
      OG000
      value
      9
    units
    Participants
description
Event free survival is the time to treatment failure from the time of study enrollment to tumor progression, tumor recurrence, death from any cause or occurrence of a second malignant neoplasm.
groups
  1. description
    Participants with juvenile pilocytic astrocytomas or optic pathway gliomas receiving PEGINTRON based on their weight (1 mcg/kg/dose) once a week, for up to two years
    id
    OG000
    title
    PEGINTRON
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Month 12, Month 24
title
Number of Participants Meeting Event Free Survival Criteria
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice